LIVECAST Markets Briefs Calendar Search

Research

Macro Politics Crypto Prediction Markets Disclosure Wire News Archive

LIVECAST Markets

Menu

Home LIVECAST Markets Briefs Calendar Search Macro Politics Crypto Prediction Markets Disclosure Wire News Archive

Live News EQUITY L impact Jul 27, 2026, 09:32 AM UTC

TLT green pm

TLT green pm

SquawkNews Newsroom

TLT green pm

Use this page

Share or save this market-moving headline as a permanent SquawkNews URL. The live feed continues at /news.

Open live news feed Browse news archive Browse news categories Search related coverage

Related tickers

No ticker tags on this item.

Related stories

RIO On Monday, Rio Tinto Group (RIO) and the Western Australian Government announced a non-binding agreements with Yindjibarndi WaterCo. for RIO On Monday, Rio Tinto Group (RIO) and the Western Australian Government announced a non-binding agreements with Yindjibarndi WaterCo. for sale of their Joint venture shares in t L impact | EQUITY | Jul 27, 2026, 10:41 AM UTC In Asian markets, The Nikkei Index gained 320 points to 64,931, the Shanghai Index gained 44 points to 3,858, and the Hang Seng Index advanc In Asian markets, The Nikkei Index gained 320 points to 64,931, the Shanghai Index gained 44 points to 3,858, and the Hang Seng Index advanced 243 points to 25,207. In Europe, the L impact | EQUITY | Jul 27, 2026, 10:41 AM UTC German Lender NordLB to Expand Into Fund Finance and CLOs German lender NordLB is seeking to boost its capital markets business by ramping up lending to third-party funds and packaging loans sold to investors. L impact | EQUITY | Jul 27, 2026, 10:40 AM UTC GM +1.9% premarket after being upgraded to buy from hold at Jefferies GM +1.9% premarket after being upgraded to buy from hold at Jefferies L impact | EQUITY | Jul 27, 2026, 10:39 AM UTC AZN Astrazeneca Plc - update on ultomiris phase III trial in hsct-tma Astrazeneca - ultomiris phase III trial in adults and adolescents with AZN Astrazeneca Plc - update on ultomiris phase III trial in hsct-tma Astrazeneca - ultomiris phase III trial in adults and adolescents with hsct-tma did not meet primary endpoint L impact | EQUITY | Jul 27, 2026, 10:38 AM UTC PERF - Perfect Corp. Reports Unaudited Financial Results for the Three Months and Six Months Ended June 30, 2026 - Click For Release PERF - Perfect Corp. Reports Unaudited Financial Results for the Three Months and Six Months Ended June 30, 2026 - Click For Release L impact | EQUITY | Jul 27, 2026, 10:37 AM UTC

SQUAWK/NEWS

Real-time financial news agency for traders. Market-relevant headlines on screen and read aloud through the LiveCast audio squawk.

Pro plan coming — join the list.

Product

LiveCast
Live Markets
Session Briefs
Calendar
Search

Research

Macro
Politics
Crypto
Prediction Markets
Disclosure Wire
News Archive

For Traders

Market Movers
US Stocks
News for Traders
How to Trade News
What Is a Squawk
Policy Calendar

Company

About
Why SquawkNews
Newsroom
Editorial Standards
Corrections
Contact

Legal

Privacy Policy
Terms of Use

© 2026 SquawkNews robots / sitemap Privacy Policy SquawkNews publishes factual market information and context. It is not investment advice and does not provide trade recommendations.

We use analytics (GA4, Clarity, PostHog) to improve the product. Privacy Policy